Clinical

Dataset Information

0

Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis


ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Irinotecan may be effective in treating patients with abnormal liver or kidney function or who have received radiation therapy. PURPOSE: Phase I trial to study the effectiveness of irinotecan in treating patients with solid tumors or lymphoma who have abnormal liver or kidney function or who have had previous radiation therapy to the pelvis.

DISEASE(S): Small Intestine Cancer,Angioimmunoblastic T-cell Lymphoma,Lymphoma,Intestinal Neoplasms,Unspecified Adult Solid Tumor, Protocol Specific

PROVIDER: 2002903 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2022-01-26 | GSE151930 | GEO
2026-02-21 | GSE310417 | GEO
| PRJNA637756 | ENA
| PRJNA1020856 | ENA
2024-03-12 | PXD045880 | Pride
| PRJNA1399451 | ENA
| PRJNA1365913 | ENA
2011-03-02 | GSE8941 | GEO
| PRJNA564726 | ENA
2011-03-02 | E-GEOD-8941 | biostudies-arrayexpress